![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » BD DIAGNOSTICS ANNOUNCES AVAILABILITY IN AFRICA OF NEW CD4 STABILIZATION BLOOD COLLECTION TECHNOLOGY
BD DIAGNOSTICS ANNOUNCES AVAILABILITY IN AFRICA OF NEW CD4 STABILIZATION BLOOD COLLECTION TECHNOLOGY
August 14, 2006
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced immediate availability in Africa of the BD Vacutainer CD4 Stabilization Blood Collection Tube. The new device is designed to improve the accuracy of CD4 test results
for HIV-infected patients and reduce healthcare costs associated with the CD4
testing process in the more remote areas of Africa, where blood specimens are
often exposed to temperatures greater than 20-25 degrees Celsius (C).
PR
Newswire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct